John F. Ginascol, EXECUTIVE VICE PRESIDENT at ABBOTT LABORATORIES (ABT), sold 5,088 shares at $120.61 ($618K) on 2021-03-01, disclosed to the SEC on 2021-03-02.
Scheduled sale ($618k) by EXECUTIVE VICE PRESIDENT under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $121.58 | 4,736 | $576K | 93.1% |
| 2 | $120.61 | 352 | $42K | 6.9% |
| Total | $121.51 avg | 5,088 | $618K | 100% |
| Filing → |
| ABT | SELL | 2022-03-02 | $43K | — | Filing → |
| ABT | SELL | 2020-04-23 | $12.1M | — | Filing → |
| ABT | SELL | 2020-03-03 | $591K | — | Filing → |